melanoma

Yervoy-Zelboraf combo trial stopped on toxicity worries
Fierce Pharma
Thu, 04/4/13 - 02:05 pm
Zelboraf
Yervoy
Bristol-Myers Squibb
melanoma
Roche
Amgen's And Vical's Melanoma Trials: Questions
Seeking Alpha
Thu, 03/28/13 - 10:38 am
Amgen
Vical
melanoma
Recent Melanoma Trial Data Has Biotech Stocks Moving
Seeking Alpha
Wed, 03/27/13 - 12:31 pm
melanoma
Amgen
TVEC
Talimogene Laherparepvec
ImmunoPulse
OncoSec
2 Cancer Biotechs With Upcoming FDA Approval Decisions In 2013
Seeking Alpha
Sat, 03/23/13 - 09:00 am
Delcath
Aveo Pharmaceutical
tivozanib
renal cell carcinoma
Chemosat
melanoma
metastatic melanoma
Modified Cold Sore Virus Shrinks Melanoma Tumors, Amgen Says
Forbes
Wed, 03/20/13 - 11:54 am
melanoma
Amgen
GM-CSF
Pipeline Progress at Glaxo
Yahoo/Zacks
Tue, 02/5/13 - 10:33 am
GSK
dabrafenib
melanoma
GlaxoSmithKline Begins Phase 3 Melanoma Study
Motley Fool
Mon, 02/4/13 - 11:24 am
GSK
melanoma
BRAF inhibitor
dabrafenid
MEK inhibitor
trametinib
Genentech takes Exelixis drug into Phase III melanoma trial
Bizjournals.com
Thu, 01/17/13 - 10:19 am
Exelixis
Genentech
melanoma
Roche
Zelboraf
GDC-0973
Vical's Allovectin: Update On The Phase III Trial
Seeking Alpha
Thu, 11/8/12 - 10:50 am
Vical
Allovectin
Bristol-Myers Squibb
JNJ
melanoma
Ziopharm - Making Progress in Advanced Melanoma
Yahoo/Reuters
Mon, 10/29/12 - 11:37 am
melanoma
Ziopharm
Ad-RTS IL-12
This Big Biotech Has a Big Winner
Motley Fool
Sat, 10/6/12 - 11:34 am
Celgene
Abraxane
breast cancer
melanoma
Exelixis: First Partnered Program Enters Phase III
Seeking Alpha
Wed, 10/3/12 - 11:20 am
Exelixis
Roche
GSK
GDC-0973
MEK inhibitor
melanoma
New Four- and Five-Year Survival Data for YERVOY® (ipilimumab) in Treatment-Naïve and Previously-Treated Metastatic Melanoma Presented at the ESMO 2012 Congress (European Society for Medical Oncology)
Yahoo/BusinessWire
Sat, 09/29/12 - 12:24 pm
Yervoy
melanoma
Bristol-Myers Squibb
Exelixis Announces Data Presentation for GDC-0973 (XL518)
Yahoo/BusinessWire
Sat, 09/29/12 - 11:59 am
Exelixis
GDC-0973
XL518
melanoma
Glaxo Two-Drug Melanoma Combo Slows Cancer in Study
Bloomberg
Sat, 09/29/12 - 11:55 am
GSK
melanoma
dabrafenib
trametinib
Bristol-Myers Squibb And The Promise Of Cancer Immunotherapy
Seeking Alpha
Tue, 09/25/12 - 11:53 am
Bristol-Myers Squibb
melanoma
Yervoy
Report: Roche's Zelboraf, BMS' Yervoy control their segment
Fierce Pharma
Fri, 09/21/12 - 01:13 pm
Roche
Zelboraf
Bristol-Myers Squibb
Yervoy
melanoma
Roche’s Skin Cancer Treatment Delayed By U.K. Drug-Cost Agency
Bloomberg
Fri, 08/10/12 - 10:09 am
UK
Roche
melanoma
Zelboraf
Glaxo Files Two Melanoma Drugs For U.S., Europe Approvals
Bloomberg
Fri, 08/3/12 - 11:23 am
melanoma
GSK
trametinib
dabrafenib
Yervoy Vs. Zelboraf: Melanoma Drugs Battle For Market Share
Seeking Alpha
Tue, 07/24/12 - 11:25 pm
Zelboraf
Yervoy
melanoma
GSK
Bristol-Myers Squibb
Roche

Pages